Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Treasury Stock	Total
Balance at Mar. 31, 2019	$ 7	$ 903,803	$ (878,884)	$ (1,772)	$ 23,154
Balance (in shares) at Mar. 31, 2019	7,216,910			26,239
Increase (Decrease) in Stockholders' Equity
Purchase of treasury stock (in shares)				78
Vested restricted stock awards (in shares)	229
Stock-based compensation		262			262
Issuance of common stock, net of issuance costs	$ 1	1,221			1,222
Issuance of common stock, net of issuance costs (in shares)	143,387
Net loss			(5,593)		(5,593)
Balance at Jun. 30, 2019	$ 8	905,286	(884,477)	$ (1,772)	19,045
Balance (in shares) at Jun. 30, 2019	7,360,526			26,317
Balance at Mar. 31, 2019	$ 7	903,803	(878,884)	$ (1,772)	23,154
Balance (in shares) at Mar. 31, 2019	7,216,910			26,239
Increase (Decrease) in Stockholders' Equity
Net loss					(10,041)
Balance at Sep. 30, 2019	$ 15	910,278	(889,000)	$ (1,798)	19,495
Balance (in shares) at Sep. 30, 2019	8,005,056			30,304
Balance at Jun. 30, 2019	$ 8	905,286	(884,477)	$ (1,772)	19,045
Balance (in shares) at Jun. 30, 2019	7,360,526			26,317
Increase (Decrease) in Stockholders' Equity
Purchase of treasury stock				$ (26)	(26)
Purchase of treasury stock (in shares)				3,987
Vested restricted stock awards		26			26
Vested restricted stock awards (in shares)	1,250
Stock-based compensation		104			104
Issuance of common stock, net of issuance costs	$ 7	4,808			4,815
Issuance of common stock, net of issuance costs (in shares)	616,443
Exercise of stock options and employee stock purchases		3			3
Exercise of stock options and employee stock purchases (in shares)	522
Stock awards to Board of Directors		(24)			(24)
Stock awards to Board of Directors (in shares)	26,315
Deemed dividend on purchase warrant for common shares		75	(75)
Net loss			(4,448)		(4,448)
Balance at Sep. 30, 2019	$ 15	910,278	(889,000)	$ (1,798)	19,495
Balance (in shares) at Sep. 30, 2019	8,005,056			30,304
Balance at Mar. 31, 2020	$ 10	915,755	(900,869)	$ (1,875)	$ 13,021
Balance (in shares) at Mar. 31, 2020	10,286,366			57,577	10,228,789
Increase (Decrease) in Stockholders' Equity
Purchase of treasury stock				$ (4)	$ (4)
Purchase of treasury stock (in shares)				3,442
Vested restricted stock awards		4			4
Vested restricted stock awards (in shares)	16,126
Stock-based compensation		210			210
Issuance of common stock, net of issuance costs	$ 1	1,371			1,372
Issuance of common stock, net of issuance costs (in shares)	782,448
Change in warrants valuation		99			99
Net loss			(1,823)		(1,823)
Balance at Jun. 30, 2020	$ 11	917,439	(902,692)	$ (1,879)	12,879
Balance (in shares) at Jun. 30, 2020	11,084,940			61,019
Balance at Mar. 31, 2020	$ 10	915,755	(900,869)	$ (1,875)	$ 13,021
Balance (in shares) at Mar. 31, 2020	10,286,366			57,577	10,228,789
Increase (Decrease) in Stockholders' Equity
Net loss					$ (6,035)
Balance at Sep. 30, 2020	$ 11	917,674	(906,919)	$ (1,918)	$ 8,848
Balance (in shares) at Sep. 30, 2020	11,143,708			70,422	11,073,286
Balance at Jun. 30, 2020	$ 11	917,439	(902,692)	$ (1,879)	$ 12,879
Balance (in shares) at Jun. 30, 2020	11,084,940			61,019
Increase (Decrease) in Stockholders' Equity
Purchase of treasury stock				$ (39)	(39)
Purchase of treasury stock (in shares)				9,403
Vested restricted stock awards		39			39
Vested restricted stock awards (in shares)	1,670
Stock-based compensation		219			219
Stock awards to Board of Directors		(38)			(38)
Stock awards to Board of Directors (in shares)	57,098
Deemed dividend on purchase warrant for common shares		15	(15)
Net loss			(4,212)		(4,212)
Balance at Sep. 30, 2020	$ 11	$ 917,674	$ (906,919)	$ (1,918)	$ 8,848
Balance (in shares) at Sep. 30, 2020	11,143,708			70,422	11,073,286